Initially, we used the human epithelial cell line A549 as A549 cells express v3 integrin in their focal adhesions (FAs) (Fig
Langman CB, Greenbaum LA, Sarwal M, Grimm P, Niaudet P, Deschenes G, Cornelissen E, Morin D, Cochat P, Matossian D, Gaillard S, Bagger MJ, Rioux P (2012) A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety
Except of its antioxidant effects or the effects on telomeres, it seems that the peptide also changes the expression of certain genes
Body Weight Adjustments While not universally applied, some research protocols adjust KLOW blend peptide dosing based on body weight: Under 150 lbs: 250-350mcg daily 150-200 lbs: 350-450mcg daily Over 200 lbs: 450-550mcg daily These ranges serve as general guidelines rather than strict rules
Human & Experimental Toxicology 2011
No receptor has been identified